Novo Nordisk Warns Consumers About Counterfeit Ozempic (semaglutide) Injection 1 mg in the US
PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the US. The US Food and Drug Administration (FDA) has also updated its website with information about these counterfeit versions of Ozempic.
The seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits 51746517 (illustrated above). Lot number PAR0362 is an authentic lot number. Only when both the lot number is coupled with the eight digits 51746517, it is counterfeit and should not be used.
As the investigation continues, further analyses, including extensive visual examination and chemical testing of the seized, counterfeit product is underway. Accordingly, neither Novo Nordisk nor FDA can confirm the contents or quality of the counterfeit product, which may present a safety risk for patients who use the counterfeit product.
WHAT TO DO: GUIDANCE FOR RETAILERS AND CONSUMERSRetail pharmacies are advised to purchase authentic Ozempic® (semaglutide) injection 1 mg and other semaglutide-containing medicines through authorized distributors of Novo Nordisk. Pharmacies are encouraged to review the photographs and information provided above. If there are any concerns about whether your batches are authentic, please call Novo Nordisk customer care at 1-800-727-6500 Monday through Friday from 8:30 AM to 6:00 PM EST.
Patients should double-check their Ozempic® box to see if it has the lot number PAR0362, and serial number beginning with the first eight digits, 51746517. These products are deemed counterfeit and should not be used. It is important to note that lot number PAR0362 is an authentic lot number. It is counterfeit product only when that lot number has those eight digits in the serial number.
Patients are encouraged to only acquire authentic Novo Nordisk Ozempic® (semaglutide) injection 1 mg through pharmacies and to check the product for any signs of counterfeiting before using.
Websites selling counterfeit and/or tampered medicines should be reported to FDA. Suspected counterfeit products may be reported to FDA by calling your local FDA consumer complaint coordinator or by reporting it directly here Report Suspected Criminal Activity (fda.gov).
Learn more about the responsible use of semaglutide-containing medicines, how to spot counterfeit products and the significant safety and health risks associated with compounded or knock-off "semaglutide" at www.semaglutide.com.
About Novo NordiskNovo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way. With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs over 10,000 people throughout the country across 12 manufacturing, R&D, and corporate locations in eight states plus Washington DC. For more information, visit novonordisk-us.com, Facebook, Instagram, and X.
SOURCE Novo Nordisk, Inc.
Posted : 2025-04-15 12:00
Read more

- Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection
- Geospatial Clustering Seen in Pediatric Firearm Injuries
- Therapy Dogs May Reduce Child, Parent Anxiety in the Emergency Department
- Increase in Internalizing Behaviors in Teens Observed Over Last 30 Years
- 1 in 3 Children Now Suffer From Chronic Illness
- Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions